Jessica Trevino Jones, M.D.
Medical Oncology Physician · San Antonio, TX
Jessica Trevino Jones, M.D. is a medical oncology physician with a practice address in San Antonio, Texas, and NPI 1982040184, issued on May 14, 2013. Check the license (Texas R2136, as entered in NPPES) on the Texas Medical Board; the Medicare figures below come from public CMS files.
- Name
- Jessica Trevino Jones
- Credential
- M.D.
- Primary taxonomy
- Medical Oncology Physician 207RX0202X
- License number
- R2136 TX
Self-reported in NPPES; status is on the state search - Practice location
- 7979 Wurzbach RD, San Antonio, TX 78229
- Phone
- (210) 450-1143
- Enumerated
- May 14, 2013
- Record last updated
- Aug 8, 2024
- Fax
- (210) 450-0407
- Medicaid ID
- 376166001 TX
- Medicare enrollment
- Enrolled (PECOS I20171002001073); accepts Medicare assignment
- Medical or professional school
- University Of Texas Medical School At San Antonio, 2013
- Telehealth
- Offers telehealth (CMS)
- Entity
- Type 1 · individual
Also registered at 7979 Wurzbach RD
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Christina Agyin, APRN-BC FNPFamily Nurse Practitioner1386831386
- Brittany Altermatt, ANPAdult Health Nurse Practitioner1902939358
- Elise Alvarez, MS, GCGenetic Counselor (M.S.)1609691005
- Shammi Anholt, PTPhysical Therapist1821745712
- Athanassios Argiris, MDHematology & Oncology Physician1174608509
- Sukeshi Arora, MDMedical Oncology Physician1386805604
Verify Jessica Trevino Jones in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersTexas Medical Board
Search for license R2136Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
10% more Medicare Part D claims than the average medical oncology physician in 2024
771 Medicare Part D claims for 161 beneficiaries, against an average of 703 among the 4,230 providers of this specialty who prescribed in Part D. 64 claims were for opioids.
Most prescribed
- Anastrozole128 claims
- Letrozole32 claims
- Gabapentin28 claims
- Raloxifene Hcl25 claims
- Tamoxifen Citrate21 claims
- Hydrocodone-Acetaminophen18 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
The practice group's MIPS final score for 2023 (Medicare payment program): 82.4 of 100
The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.
Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).
Industry payments in 2024: $307.93
7 payments; by number, the most common kind was food and beverage; the largest payer was Stemline Therapeutics Inc. The 3,343 providers of this specialty with any payment received $11,773.47 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through one group practice
- University OF Texas Health Science Center AT San AntonioSan Antonio, TX
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Medical Oncology Physician providers in Texas
There are 547 medical oncology physician records in Texas.
Other medical oncology physician records in Texas
- Chinemerem Abanonu, MDKaty, TX1396972659
- James Abbruzzese, M.D.Houston, TX1134233224
- Maen Abdelrahim, MDHouston, TX1518227735
- Sausan Abouharb, M.DHouston, TX1205097599
- Fadi Abu-Shahin, MDHouston, TX1215123971
- Laith Abushahin, MBBSDallas, TX1326288564
- John Adams, DOArlington, TX1548262900
- Kerin Adelson, M.D.Houston, TX1285846790
- Sachin Agarwal, M.D.College Station, TX1386867448
- Cristi Aitelli, D.O.Fort Worth, TX1578773511
Common questions
What is Jessica Trevino Jones, M.D.'s NPI number?
Jessica Trevino Jones, M.D.'s National Provider Identifier (NPI) is 1982040184, issued on May 14, 2013. An NPI identifies a provider in billing; it is not a license.
Where is Jessica Trevino Jones, M.D. located?
The NPPES record lists a practice address at 7979 Wurzbach RD, San Antonio, TX, 78229. Phone: (210) 450-1143. Providers update this record themselves, so call before visiting.
How can I verify Jessica Trevino Jones, M.D.'s license?
NPPES lists Texas license number R2136, as entered by the provider. Search the Texas Medical Board at https://profile.tmb.state.tx.us/Search.aspx. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Jessica Trevino Jones, M.D. prescribe under Medicare Part D?
In 2024, Jessica Trevino Jones, M.D. had 771 Medicare Part D claims for 161 beneficiaries; the average among medical oncology physician prescribers was 703. Part D covers Medicare prescriptions only.
What is Jessica Trevino Jones, M.D.'s MIPS final score?
The 2023 MIPS final score is 82.4 of 100, reported for the practice group. The average among 454,083 clinicians with a measured score was 83.5.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.